Page last updated: 2024-09-04

docetaxel anhydrous and Absence Seizure

docetaxel anhydrous has been researched along with Absence Seizure in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Xie, L	1
Armstrong, AJ; Chi, KN; de Bono, JS; de Wit, R; Fizazi, K; Flaig, TW; Fléchon, A; Fleming, M; Hainsworth, JD; Hirmand, M; Mainwaring, P; Miller, K; Mulders, P; Saad, F; Scher, HI; Seely, L; Selby, B; Shore, ND; Sternberg, CN; Taplin, ME	1

Trials

1 trial(s) available for docetaxel anhydrous and Absence Seizure

Article	Year
Increased survival with enzalutamide in prostate cancer after chemotherapy. The New England journal of medicine, 2012, Sep-27, Volume: 367, Issue:13 Topics: Aged; Androgen Receptor Antagonists; Antineoplastic Agents; Benzamides; Disease-Free Survival; Docetaxel; Double-Blind Method; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostatic Neoplasms; Seizures; Signal Transduction; Taxoids	2012

Article

Year

Increased survival with enzalutamide in prostate cancer after chemotherapy.

The New England journal of medicine, 2012, Sep-27, Volume: 367, Issue:13

Topics: Aged; Androgen Receptor Antagonists; Antineoplastic Agents; Benzamides; Disease-Free Survival; Docetaxel; Double-Blind Method; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Nitriles; Orchiectomy; Phenylthiohydantoin; Prostatic Neoplasms; Seizures; Signal Transduction; Taxoids

2012

Other Studies

1 other study(ies) available for docetaxel anhydrous and Absence Seizure

Article	Year
Posterior reversible encephalopathy syndrome triggered by FLOT (5-fluorouracil, oxaliplatin, docetaxel, and calcium levofolinate) chemotherapy and thrombocytopenia (docetaxel and cisplatin) chemotherapy. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2023, Volume: 29, Issue:6 Topics: Calcium; Cisplatin; Docetaxel; Edema; Female; Fluorouracil; Headache; Humans; Leucovorin; Middle Aged; Oxaliplatin; Posterior Leukoencephalopathy Syndrome; Seizures; Thrombocytopenia	2023

Article

Year

Posterior reversible encephalopathy syndrome triggered by FLOT (5-fluorouracil, oxaliplatin, docetaxel, and calcium levofolinate) chemotherapy and thrombocytopenia (docetaxel and cisplatin) chemotherapy.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2023, Volume: 29, Issue:6

Topics: Calcium; Cisplatin; Docetaxel; Edema; Female; Fluorouracil; Headache; Humans; Leucovorin; Middle Aged; Oxaliplatin; Posterior Leukoencephalopathy Syndrome; Seizures; Thrombocytopenia

2023